Business Problem: 

Launching a Novel High-Value Molecular Assay for the Early Identification of Colon Cancer (CRC).

Company Objective: Secure lead customers, reinforce value proposition, demonstrate value of assay to secure partnership deals in international markets.

Solution: 

Build Health Economic Argumentation to support premium pricing, secure first company revenues from KOL, demonstrate value of technology to support international partnerships.

Outcome: 
Established first revenue stream for new disruptive technology, supported international deal making.